tiprankstipranks
Advertisement
Advertisement
Fresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year
PremiumThe FlyFresenius Medical reports Q4 EPS ex-items EUR1.44 vs. EUR0.91 last year
2M ago
Fresenius Medical sees 2026 revenue growth flat vs. EUR19.63B in 2025
Premium
The Fly
Fresenius Medical sees 2026 revenue growth flat vs. EUR19.63B in 2025
2M ago
Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds
Premium
Ratings
Sell Rating on Fresenius Medical Care Amid Unsustainable Earnings Quality and Structural Headwinds
2M ago
Weak Operating Momentum, Limited Earnings Visibility, and 2026 Headwinds Drive Underperform (Sell) Rating and Price Target Cut to €32
PremiumRatingsWeak Operating Momentum, Limited Earnings Visibility, and 2026 Headwinds Drive Underperform (Sell) Rating and Price Target Cut to €32
3M ago
Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi
Premium
The Fly
Fresenius Medical price target lowered to EUR 39.50 from EUR 48.50 at Citi
3M ago
Fresenius Medical downgraded to Neutral from Buy at Goldman Sachs
Premium
The Fly
Fresenius Medical downgraded to Neutral from Buy at Goldman Sachs
3M ago
Cautious Outlook for Fresenius Medical Care Amid Sector Challenges and Persistent Headwinds
PremiumRatingsCautious Outlook for Fresenius Medical Care Amid Sector Challenges and Persistent Headwinds
4M ago
Fresenius Medical Care Appoints New Global Chief Medical Officer
Premium
Company Announcements
Fresenius Medical Care Appoints New Global Chief Medical Officer
4M ago
Fresenius Medical names Charles Hugh-Jones as Global Chief Medical Officer
Premium
The Fly
Fresenius Medical names Charles Hugh-Jones as Global Chief Medical Officer
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100